Seborrheic Dermatitis Treatment Market is growing at a CAGR of 11.0% from 2022 to 2031 | ALMIRALL S.A., Bausch Health Companies Inc., D3 Development, Inc, F. Hoffman-La Roche AG, GlaxoSmithKline plc.

The global seborrheic dermatitis treatment industry generated $2.3 billion in 2021, and is anticipated to generate $6.6 billion by 2031, witnessing a CAGR of 11.0% from 2022 to 2031.

Leading Market Players: -

ALMIRALL S.A.
Aurobindo Pharma Ltd.
Bausch Health Companies Inc.
D3 Development Inc.
F. HOFFMAN-LA ROCHE AG
GlaxoSmithKline PLC
LEO PHARMA A/S
lupin Limited
Medimetricks Pharmaceutical Inc.
Sun Pharmaceutical Industries Ltd.

Download Free Sample Report-

https://www.alliedmarketresearch.com/request-sample/13783

The rise in the number of autoimmune diseases such as HIV (human immunodeficiency virus), and psoriasis, technological advancement in healthcare sector, increase in the number of research activities, increase in the number dermatological clinics, and rise in number of treatment options for seborrheic dermatitis drive the growth of the global seborrheic dermatitis treatment market. However, high cost of treatment options for seborrheic dermatitis, availability of home remedies and other treatment options for seborrheic dermatitis restrict the market growth. Moreover, rise in adoption of key strategies such as collaboration, acquisition, agreement and partnership by seborrheic dermatitis treatment industry that manufacture seborrheic dermatitis treatment device present new opportunities in the coming years.

Alarming rise in the number of autoimmune diseases such as HIV (human immunodeficiency virus), and psoriasis, technological advancement in healthcare sector and increase in the number of research activities leads to the growth of the Seborrheic Dermatitis Treatment Market.

Seborrheic dermatitis treatment is used to prevent skin infection, lowers swelling, remove flaky dandruff, and reduce itching of the scalp and other body parts as the geriatric population with low immune system are more prone to seborrheic dermatitis. Thus, rise in number of geriatric populations increases the demand for seborrheic dermatitis treatment, which drives the market growth.

Covid-19 on Seborrheic Dermatitis Treatment Market:

The outbreak of the Covid-19 pandemic had a negative impact on the global seborrheic dermatitis treatment market. Most of the diagnostic cases are postpone or rescheduled due to conversion of dermatological clinics, diagnostic centers into COVID hospitals.

Decrease in the number of consultations for skin diseases due the COVID-19 outbreak hampered the growth of seborrheic dermatitis treatment market. As COVID-19 was highly infectious, doctors needed protective equipment kit (PPE Kit) in their clinics for treatment and diagnosis purpose.

Moreover, sharp cut in disposable income of people and decrease in adoption of drugs for non-emergency treatment also restrained the market growth. There was delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions affected facilities and supply chain.

For Purchase Inquiry-

https://www.alliedmarketresearch.com/purchase-enquiry/13783

Key Findings of The Study

By dosage form, the cream segment was the highest contributor to the market in 2021.

By treatment, the antifungal segment was the highest contributor to the market in 2021.

By type, the anti-fungal segment dominated the market in 2021, and is expected to continue this trend during the forecast period.

By distribution channel, the prescription-based drugs segment dominated the market in 2021 and is expected to continue this trend during the forecast period.

This is attributed to high presence of seborrheic dermatitis treatment industry and developed healthcare infrastructure. Asia-Pacific is anticipated to witness lucrative growth, owing to rise in awareness among the people regarding availability skin disease treatment and rise in adoption of high quality anti-fungal shampoos, lotions, creams, and foams.

Trending Reports in Healthcare Industry:

mHealth Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Healthcare IT Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

COPD and Asthma Devices Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.